Australia’s top brokers have been busy adjusting their estimates and recommendations again, leading to the release of a large number of broker notes this week.
Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:
Control Bionics Ltd (ASX: CBL)
According to a note out of Morgans, its analysts have initiated coverage on this medical device company’s shares with an add rating and $1.42 price target. The broker notes that the company’s NeuroNode technology allows severely disabled people to operate and communicate via a computer using visual and neural signals. It appears positive on its long term future and notes that it is targeting a market worth $1.2 billion a year. The Control Bionics share price is trading at 98 cents today.
Hub24 Ltd (ASX: HUB)
Analysts at Citi have retained their buy rating and $24.00 price target on this investment platform provider’s shares. The broker points out that the company has signed an agreement with IOOF Holdings Limited (ASX: IFL). While it sees some risks from the deal, overall it views it as a positive. In addition to this, the broker believes HUB24 is well-placed to benefit from the ongoing structural shift in wealth management. The HUB24 share price is changing hands for $20.82 on Thursday.
Medibank Private Ltd (ASX: MPL)
A note out of Morgan Stanley reveals that its analysts have retained their overweight rating and $3.15 price target on this private health insurer’s shares. This follows the decision of the Federal Government to authorise a 3.25% increase in its premiums in 2021. It believes this is a positive for Medibank, though acknowledges that increasing premiums could lead to affordability issues for consumers. The Medibank share price is changing hands for $3.01 on Thursday afternoon.
EARLY ACCESS – Our Boxing Day Sale – Save over 60% off Motley Fool Share Advisor
Right now we’re offering EARLY ACCESS to our Boxing Day sale. We’re giving you the chance to join Scott Phillips within our signature stock picking service, Motley Fool Share Advisor, for as little as $149 for a whole year’s membership.
And now is a perfect time to join during this Boxing Day Sale and collect a whopping 60% off
More reading
- Why the Hub24 (ASX:HUB) share price could go higher
- ASX 200 ends slightly down
- Why the Medibank (ASX:MPL) share price surged 4% higher today
- ASX 200 down 0.4%: NIB jumps, a2 Milk rebounds, WiseTech sinks lower
- Here’s what is driving the NIB (ASX:NHF) share price higher today
James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Hub24 Ltd. The Motley Fool Australia owns shares of CBL Limited. The Motley Fool Australia has recommended Hub24 Ltd. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
The post Brokers name 3 ASX shares to buy right now appeared first on The Motley Fool Australia.
from The Motley Fool Australia https://ift.tt/3roPgx5
Leave a Reply